Following a recent analysis of the global wearable injectors market size, the market was valued at USD 6.75 Billion in 2020 and is expected to exceed USD 15.66 Billion in terms of revenue, at a CAGR of 11.2% over 2021-2028. Rise in incidence of CVDs and diabetes among aged population and surging need for more efficient drug administering devices and solutions are the key factors driving wearable injectors market growth.
Increasing focus of patient on avoiding treatments that involve painful injections or risk of needle stick injuries are other key factors driving the demand for wearable injectors. These injectors enable users to track and manage therapy, avoid double injections, missed injections or over-dose. Wearable injectors also aid in improving patient adherence thereby bringing better therapy outcomes. In addition, advantageous product features, including lightweight, prefilled glass cartridge, and high tolerant adhesive nature will drive wearable injectors market trends through 2028.
Grab Your Free Sample PDF Copy Now
Some Key Highlights in the Report
- Based on technology, the spring-based segment is expected to account for a major chunk of the wearable injectors market share through over the analysis period on account of increased preference for the technology as it offers better efficacy as compared to conventional procedures.
- Based on type, the on-body wearable injectors segment is forecast to observe considerable growth through 2028. The On-body wearable injectors are more comfortable, cost-effective and also enable patients to self-administer treatments at home.
- Based on application, the immune-oncology is the fastest growing segment for the wearable injectors market on account increasing prevalence of cancer among aged population coupled with surging adoption of wearable injectors due to their cost-effectiveness and ease of use.
- Based on end-use, the home care setting segment is forecast to contribute significantly to the market revenue share over the forecast period on account of increasing R&D initiatives for the production of more cost-effective and advanced self-injection systems for in-home usage.
- In the regional landscape, North America accounted for majority of the global wearable injectors market share in 2020 and is expected to observe fastest growth through 2028. The robust growth can be attributed to the presence of major players such as Insulet Corporation, Amgen, Becton, Enable Injections, United Therapeutics Corporation, and Dickinson And Company in the region will favour industry growth.
- Key players operating in the global wearable injectors market include Amgen, Hoffmann-La Roche AG, Medtronic, Ypsomed, West Pharmaceutical Services, Insulet Corporation, Becton, Enable Injections, United Therapeutics Corporation, Dickinson And Company and Johnson & Johnson, among others.
For the purpose of this report, Emergen Research has segmented the global wearable injectors market on the basis of technology, type, application, end-use, and region:
- Technology Outlook (Revenue, USD Billion; 2018–2028)
- Motor-driven
- Expanding Battery
- Spring-based
- Rotary Pump
- Others
- Type Outlook (Revenue, USD Billion; 2018–2028)
- Off-body
- On-body
- Application Outlook (Revenue, USD Billion; 2018–2028)
- Cardiovascular Disease
- Diabetes
- Immuno-Oncology
- Infectious Diseases
- Others
- End-use Outlook (Revenue, USD Billion; 2018–2028)
- Clinics
- Hospitals
- Home Care Settings
- Others
- Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
- North America
To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/wearable-injectors-market